INTER-B NHL-RITUX-2010 TRIAL FOR CHILDREN/ADOLESCENTS WITH HIGH-RISK MATURE B-NHL: SAFETY AND EFFICACY IN PATIENTS TREATED WITH RITUXIMAB AND LMB CHEMOTHERAPY

被引：0
|
作者：
Minard-Colin, V.
Auperin, A.
Burke, A.
Alexander, S.
Moreno, M.
Buffardi, S.
Uyttebroeck, A.
Bollard, C.
Zsiros, J.
Csoka, M.
Kazanowska, B.
Chiang, A.
Verschuur, A.
Miles, R.
Wotherspoon, A.
Barkauskas, D.
Wheatley, K.
Vassal, G.
Adamson, P.
Gross, T.
Patte, C.
Pillon, M.
机构：
来源：
LEUKEMIA RESEARCH | 2022年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
061
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [1] Results of the randomized Intergroup trial Inter-B-NHL Ritux 2010 for children and adolescents with high-risk B-cell non-Hodgkin lymphoma (B-NHL) and mature acute leukemia (B-AL): Evaluation of rituximab (R) efficacy in addition to standard LMB chemotherapy (CT) regimen.
    Minard-Colin, Veronique
    Auperin, Anne
    Pillon, Marta
    Burke, Amos
    Anderson, James Robert
    Barkauskas, Donald A.
    Wheatley, Keith
    Delgado, Rafael
    Alexander, Sarah
    Uyttebroeck, Anne
    Bollard, Catherine
    Zsiros, Jozsef
    Csoka, Monika
    Goma, Gisele
    Tulard, Anne
    Patte, Catherine
    Gross, Thomas G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Results of the Randomized Intergroup Trial Inter-B-NHL RITUX 2010 for Children/Adolescents with High-Risk B-Cell Non Hodgkin Lymphoma (B-NHL) and Mature Acute Leukemia (B-AL)
    Colin, V. Minard
    Auperin, A.
    Pillon, M.
    Burke, A.
    Anderson, J.
    Barkausk, D.
    Wheatley, K.
    Delgado, R.
    Alexander, S.
    Uyttebroeck, A.
    Bollard, C.
    Zsiros, J.
    Csoka, M.
    Goma, G.
    Tulard, A.
    Patte, C.
    Gross, T.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S31 - S31
  • [3] SAFETY PROFILE OF RITUXIMAB IN INITIAL TREATMENT OF CHILDREN AND ADOLESCENTS WITH MATURE B-NHL
    Finger, J.
    Schmidt, R.
    Mellgren, K.
    Gunnes, M.
    Huttunen, P.
    Kabickova, E.
    Attarbaschi, A.
    Ceppi, F.
    Wehner, P.
    Mueller, S.
    Burkhardt, B.
    LEUKEMIA RESEARCH, 2022, 121 : S24 - S24
  • [4] IMPACT OF RITUXIMAB ON IMMUNE STATUS FOLLOWING THERAPY IN CHILDREN AND ADOLESCENTS WITH HIGH-RISK MATURE B-CELL NON-HODGKIN LYMPHOMA: RESULTS OF THE INTER-B-NHL RITUX 2010 TRIAL
    Alexander, S.
    Auperin, A.
    Bomken, S.
    Csoka, M.
    Kazanowska, B.
    Chiang, A.
    Andres Moreno, M.
    Uyttebroeck, A.
    Burke, A.
    Zsiros, J.
    Pillon, M.
    Bollard, C.
    Barkauskas, D.
    Wheatley, K.
    Patte, C.
    Gross, T.
    Minard-Colin, V.
    LEUKEMIA RESEARCH, 2022, 121 : S8 - S9
  • [5] The treatment of mature B-NHL with the involvement of CNS in children and adolescents with chemotherapy and rituximab; experience of multicentral study
    Smirnova, N.
    Samochatova, E.
    Feodorova, A.
    Belogurova, M.
    Doubrovina, M.
    Khlebnikova, O.
    Litvinov, D.
    Ponomareva, N.
    Nikonova, O.
    Shamardina, A.
    Maschan, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 : 58 - 59
  • [6] Prognostic Impact of Fc Gamma-Receptor Polymorphisms and Efficacy of Rituximab in Children and Adolescents with Mature Aggressive B-NHL
    Burkhardt, Birgit
    Yavuz, Deniz
    Zimmerman, Martin
    Schieferstein, Jutta
    Kabickova, Edita
    Attarbaschi, Andishe
    Lisfeld, Jasmin
    Bonn, Bettina R.
    Reiter, Alfred
    Damm-Welk, Christine
    BLOOD, 2012, 120 (21)
  • [7] Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin’s lymphoma
    Béranger Lueza
    Anne Aupérin
    Charlotte Rigaud
    Thomas G. Gross
    Marta Pillon
    Rafael F. Delgado
    Anne Uyttebroeck
    G. A. Amos Burke
    József Zsíros
    Monika Csóka
    Mathieu Simonin
    Catherine Patte
    Véronique Minard-Colin
    Julia Bonastre
    The European Journal of Health Economics, 2024, 25 : 307 - 317
  • [8] Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin's lymphoma
    Lueza, Beranger
    Auperin, Anne
    Rigaud, Charlotte
    Gross, Thomas G.
    Pillon, Marta
    Delgado, Rafael F.
    Uyttebroeck, Anne
    Burke, G. A. Amos
    Zsiros, Jozsef
    Csoka, Monika
    Simonin, Mathieu
    Patte, Catherine
    Minard-Colin, Veronique
    Bonastre, Julia
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2024, 25 (02): : 307 - 317
  • [9] Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial
    Mori, Tetsuya
    Osumi, Tomoo
    Kada, Akiko
    Ohki, Kentaro
    Koga, Yuhki
    Fukano, Reiji
    Fujita, Naoto
    Mitsui, Tetsuo
    Mori, Takeshi
    Saito, Akiko M.
    Nakazawa, Atsuko
    Kobayashi, Ryoji
    Sekimizu, Masahiro
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (04) : 585 - 593
  • [10] Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy
    Gerrard, Mary
    Waxman, Ian M.
    Sposto, Richard
    Auperin, Anne
    Perkins, Sherrie L.
    Goldman, Stanton
    Harrison, Lauren
    Pinkerton, Ross
    McCarthy, Keith
    Raphael, Martine
    Patte, Catherine
    Cairo, Mitchell S.
    BLOOD, 2013, 121 (02) : 278 - 285
12345